Hem › Melanom › North Carolina
Kliniska studier för Melanom i North Carolina
31 studier för Melanom söker deltagare vid platser i North Carolina.
Städer i North Carolina
- Durham21 studier
- Charlotte7 studier
- Winston-Salem4 studier
- Goldsboro4 studier
- Wilson3 studier
- Jacksonville3 studier
- Asheville3 studier
- Greenville3 studier
Officiell studietext (engelska)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Carolina Cancer Research Center, Wilson
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06270706Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- AdventHealth Infusion Center Asheville, Asheville
- Southeastern Medical Oncology Center-Clinton, Clinton
- AdventHealth Infusion Center Haywood, Clyde
- och 6 fler
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
- Lineberger Comprehensive Cancer Center, Chapel Hill
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT07740941DESTINY-PANTUMOUR04
- Research Site, Durham
- Research Site, Wilson
RekryterarObservationsstudie
Ålder 18 till 130 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07124000BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Southeastern Medical Oncology Center-Clinton, Clinton
- Southeastern Medical Oncology Center-Goldsboro, Goldsboro
- Southeastern Medical Oncology Center-Jacksonville, Jacksonville
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT05136196A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Messino Cancer Center, Asheville
- Levine Cancer Institute, Charlotte
- Novant Health Cancer Institute, Charlotte
- och 3 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06246916Pan-tumor MRD Study
- Carolina Oncology Specialists, Charlotte
- Southeastern Medical Oncology Center (SMOC), Goldsboro
- Regional Medical Oncology Center, Wilson
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT06605404Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Duke Cancer Center Cary, Cary
- Duke University Medical Center, Durham
- Duke Cancer Center Raleigh, Raleigh
RekryterarFas 3
Ålder 75 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT07068074Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Carolina Biooncology Institute, Huntersville
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 18 sep. 2026 · NCT05267626A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0100, Durham
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT07492680A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Wake Forest University at Clemmons, Clemmons
- Southeastern Medical Oncology Center-Clinton, Clinton
- Southeastern Medical Oncology Center-Goldsboro, Goldsboro
- och 4 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT04511013ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- UNC- Chapel Hill, Chapel Hill
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT05059444DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
- University of North Carolina, Chapel Hill
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT07288112A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Duke Cancer Institute, Durham
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 2 sep. 2026 · NCT07070232Project: Every Child for Younger Patients With Cancer
- Mission Hospital, Asheville
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- och 4 fler
RekryterarObservationsstudie
Upp till ålder 25 · Alla kön · Uppdaterad 25 aug. 2026 · NCT02402244Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
- Lineberger Comprehensive Cancer Center, Chapel Hill
RekryterarFas 1
Ålder 18 till 99 · Alla kön · Uppdaterad 19 aug. 2026 · NCT03454035A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Clinical Trial Site, Huntersville
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 6 aug. 2026 · NCT07749586A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
- Duke University Medical Center, Durham
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 8 juli 2026 · NCT05077137Integrated Cancer Repository for Cancer Research
- Cape Fear Valley Health System, Fayetteville
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 19 till 110 · Alla kön · Uppdaterad 29 juni 2026 · NCT02012699A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill
RekryterarFas 1/2
Ålder 18 till 70 · Alla kön · Uppdaterad 15 juni 2026 · NCT06940739Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- Duke University Medical Center, Durham
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 8 juni 2026 · NCT03947385IL-17 Blockade to Decrease irAEs (REPLAY)
- Duke University Health System, Durham
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 4 juni 2026 · NCT07237594A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- University of North Carolina at Chapel Hill, Chapel Hill
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 28 apr. 2026 · NCT06413680A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Duke University Medical Center, Durham
RekryterarFas 2/3
Alla åldrar · Alla kön · Uppdaterad 2 apr. 2026 · NCT06581406Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Atrium Health Stanly/LCI-Albemarle, Albemarle
- Cone Health MedCenter Asheboro, Asheboro
- Cone Health Cancer Center at Alamance Regional, Burlington
- och 21 fler
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 17 mars 2026 · NCT06418204A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
- Carolina BioOncology Institute, Huntersville
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 21 jan. 2026 · NCT07317505Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- Duke University Medical Center - Duke Cancer Center, Durham
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 17 dec. 2025 · NCT03567889SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chapel Hill
- Massive Bio SYNERGY-AI site, Winston-Salem
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774Excision of Lymph Node Trial (EXCILYNT) (Mel69)
- Duke University Health System, Durham
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 17 sep. 2025 · NCT05839912Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke University Medical Center, Durham
- East Carolina University, Greenville
- och 1 fler
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 27 nov. 2024 · NCT03860883DermaSensor Postmarket Surveillance Study
- West Clinical Research, Morehead City
Rekryterar
Ålder 40 och äldre · Alla kön · Uppdaterad 31 okt. 2024 · NCT06666790Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.